Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00165269
Status:
COMPLETED
Last Update Posted:
2009-11-01
First Post:
2005-09-09
Brief Title:
Mantle Irradiation for Hodgkins Disease
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
Mantle Irradiation for Selected Hodgkins Disease Patients With Stage IA-IIA Disease
Status:
COMPLETED
Status Verified Date:
2009-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study it to evaluate the effectiveness of radiation therapy limited to above the diaphragm in patients with pathological stage IA-IIA Hodgkins disease
Detailed Description:
Eligble patients will receive a course of radiation therapy directed to above the diaphragm only
Patients would have bloodwork and chest x-rays performed 4 times per year for the first two years 3 times per year for the third year and 2 times per year for the fourth and fifth years After five years yearly check-ups are performed
In addition to the above follow-up patients will receive once or twice a year for the first 5 years an abdominal-pelvic CT scan andor gallium scan
Patients would have bloodwork and chest x-rays performed 4 times per year for the first two years 3 times per year for the third year and 2 times per year for the fourth and fifth years After five years yearly check-ups are performed
In addition to the above follow-up patients will receive once or twice a year for the first 5 years an abdominal-pelvic CT scan andor gallium scan
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None